SYK
Stryker Corporation NYSE$290.88
After hrs
$295.61
+0.12%
Mkt Cap $111.4B
52w Low $290.23
0.6% of range
52w High $404.87
50d MA $344.95
200d MA $364.59
P/E (TTM)
34.7x
EV/EBITDA
23.0x
P/B
5.0x
Debt/Equity
0.7x
ROE
7.2%
P/FCF
31.4x
RSI (14)
—
ATR (14)
—
Beta
0.93
50d MA
$344.95
200d MA
$364.59
Avg Volume
2.1M
About
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody syst…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | AMC | 2.98 | 2.60 | -12.8% | 315.13 | -0.6% | -6.5% | -7.7% | -7.6% | — | — | — |
| Jan 29, 2026 | AMC | 4.40 | 4.47 | +1.6% | 354.30 | +4.2% | +4.3% | +3.9% | +1.8% | +1.8% | +2.3% | — |
| Oct 30, 2025 | AMC | 3.13 | 3.19 | +1.9% | 368.98 | -1.4% | -3.5% | -2.9% | -1.7% | -3.1% | -4.1% | — |
| Jul 31, 2025 | AMC | 3.07 | 3.13 | +2.0% | 392.73 | -5.2% | -3.8% | -2.9% | -3.0% | -4.5% | -4.2% | — |
| May 1, 2025 | AMC | 2.71 | 2.84 | +4.8% | 373.99 | -0.0% | +1.1% | +2.0% | +0.9% | +2.7% | +2.3% | — |
| Jan 28, 2025 | AMC | 3.87 | 4.01 | +3.6% | 395.15 | -0.0% | -1.0% | -1.2% | -1.0% | -1.0% | -0.7% | — |
| Oct 29, 2024 | AMC | 2.77 | 2.87 | +3.6% | 359.01 | +1.9% | +1.2% | -0.8% | +2.3% | +2.2% | +3.0% | — |
| Jul 30, 2024 | AMC | 2.79 | 2.81 | +0.7% | 330.22 | +0.1% | -0.8% | +0.9% | +0.4% | -4.3% | -2.3% | — |
| Apr 30, 2024 | AMC | 2.35 | 2.50 | +6.4% | 336.50 | -0.9% | -2.5% | -2.9% | -2.4% | -3.3% | -1.3% | — |
| Jan 30, 2024 | AMC | 3.27 | 3.46 | +5.8% | 316.64 | +7.1% | +6.0% | +7.6% | +8.0% | +8.3% | +7.3% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1 | Canaccord Genuity | Maintains | Buy → Buy | — | $315.13 | $313.34 | -0.6% | -6.5% | — | — | — | — |
| May 1 | JP Morgan | Maintains | Overweight → Overweight | — | $315.13 | $313.34 | -0.6% | -6.5% | — | — | — | — |
| May 1 | Needham | Maintains | Buy → Buy | — | $315.13 | $313.34 | -0.6% | -6.5% | — | — | — | — |
| May 1 | BTIG | Maintains | Buy → Buy | — | $315.13 | $313.34 | -0.6% | -6.5% | — | — | — | — |
| May 1 | Wells Fargo | Maintains | Overweight → Overweight | — | $315.13 | $313.34 | -0.6% | -6.5% | — | — | — | — |
| May 1 | Evercore ISI | Maintains | Outperform → Outperform | — | $315.13 | $313.34 | -0.6% | -6.5% | — | — | — | — |
| Apr 15 | Truist | Maintains | Hold → Hold | — | $345.88 | $346.71 | +0.2% | -1.3% | -2.2% | -0.7% | -2.2% | -5.4% |
| Apr 14 | BTIG | Maintains | Buy → Buy | — | $347.24 | $347.84 | +0.2% | -0.4% | -1.7% | -2.6% | -1.1% | -2.6% |
| Apr 9 | Goldman Sachs | Maintains | Neutral → Neutral | — | $340.01 | $338.16 | -0.5% | -0.3% | -0.3% | +2.1% | +1.7% | +0.4% |
| Apr 7 | Citigroup | Maintains | Buy → Buy | — | $332.30 | $330.25 | -0.6% | -0.1% | +2.3% | +2.1% | +2.1% | +4.5% |
Recent Filings
8-K
Stryker Corporation -- 8-K Filing
Stryker Corporation reaffirmed its full-year 2026 guidance despite implementing organizational restructuring, signaling management confidence in underlying business performance and growth momentum.
Apr 30
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
Stryker will report Q1 FY2026 earnings April 30, 2026, providing detailed financial results and full-year guidance that investors should monitor for growth trajectory and margin performance.
Apr 9
8-K
Unknown — 8-K Filing
Palo Alto Networks' security incident appears contained to internal systems with no customer compromise, reducing litigation risk and protecting PANW's reputation and revenue relationships.
Mar 23
8-K
Unknown — 8-K Filing
Stryker disclosed a cybersecurity incident in this 8-K, creating uncertainty around operational disruption and potential financial impact that investors should monitor for earnings consequences.
Mar 12
8-K
Unknown — 8-K Filing
Stryker disclosed a significant cybersecurity incident in this 8-K, creating uncertainty around operational impact, financial costs, and potential liability exposure that investors should monitor closely.
Mar 11
Data updated apr 27, 2026 3:49am
· Source: massive.com